{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:54:41Z","timestamp":1782305681780,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,24]]},"DOI":"10.7759\/cureus.111419","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:35:29Z","timestamp":1782304529000},"source":"Crossref","is-referenced-by-count":0,"title":["Gaps in Guideline-Directed Medical Therapy for Heart Failure: A Cross-Sectional Study in an Underserved Population"],"prefix":"10.7759","author":[{"given":"Ayara O","family":"Ehinmisan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpi","family":"Jain-Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Karki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01887-4","article-title":"Guideline-directed medical therapy for the treatment of heart failure with reduced ejection fraction","volume":"83","author":"Patel J","year":"2023","unstructured":"Patel J, Rassekh N, Fonarow GC, Deedwania P, Sheikh FH, Ahmed A, Lam PH. Guideline-directed medical therapy for the treatment of heart failure with reduced ejection fraction. Drugs. 2023, 83:747-59. 10.1007\/s40265-023-01887-4","journal-title":"Drugs"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al.. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022, 145:e895-e1032. 10.1161\/CIR.0000000000001063","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.012357","article-title":"Social determinants of health and disparities in guideline-directed medical therapy optimization for heart failure","volume":"18","author":"Jacobs JA","year":"2025","unstructured":"Jacobs JA, Ayodele I, Bress AP, et al.. Social determinants of health and disparities in guideline-directed medical therapy optimization for heart failure. Circ Heart Fail. 2025, 18:e012357. 10.1161\/CIRCHEARTFAILURE.124.012357","journal-title":"Circ Heart Fail"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CP9.0000000000000073","article-title":"Enhancing implementation of evidence-based heart failure therapies in clinical practice: vital to modern medicine","volume":"9","author":"Fu M","year":"2024","unstructured":"Fu M, Swedberg K. Enhancing implementation of evidence-based heart failure therapies in clinical practice: vital to modern medicine. Cardiology Plus. 2024, 9:6-8. 10.1097\/CP9.0000000000000073","journal-title":"Cardiology Plus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.122.009078","article-title":"Validity of International Classification of Diseases (ICD)-10 diagnosis codes for identification of acute heart failure hospitalization and heart failure with reduced versus preserved ejection fraction in a national Medicare sample","volume":"16","author":"Bates BA","year":"2023","unstructured":"Bates BA, Akhabue E, Nahass MM, et al.. Validity of International Classification of Diseases (ICD)-10 diagnosis codes for identification of acute heart failure hospitalization and heart failure with reduced versus preserved ejection fraction in a national Medicare sample. Circ Cardiovasc Qual Outcomes. 2023, 16:e009078. 10.1161\/CIRCOUTCOMES.122.009078","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref6","unstructured":"Federally Qualified Health Center (FQHC). (2026). Accessed. May 2026: https:\/\/www.healthcare.gov\/glossary\/federally-qualified-health-center-fqhc\/."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/10775587231218050","article-title":"The impact of prescription drug coverage on disparities in adherence and medication use: a systematic review","volume":"81","author":"Kaplan CM","year":"2024","unstructured":"Kaplan CM, Waters TM, Clear ER, Graves EE, Henderson S. The impact of prescription drug coverage on disparities in adherence and medication use: a systematic review. Med Care Res Rev. 2024, 81:87-95. 10.1177\/10775587231218050","journal-title":"Med Care Res Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.053291","article-title":"The affordability of guideline-directed medical therapy: cost sharing is a critical barrier to therapy adoption","volume":"143","author":"Sandhu AT","year":"2021","unstructured":"Sandhu AT, Heidenreich PA. The affordability of guideline-directed medical therapy: cost sharing is a critical barrier to therapy adoption. Circulation. 2021, 143:1073-5. 10.1161\/CIRCULATIONAHA.120.053291","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2022.02","article-title":"Unequitable heart failure therapy for Black, Hispanic and American-Indian patients","volume":"8","author":"Ilonze O","year":"2022","unstructured":"Ilonze O, Free K, Breathett K. Unequitable heart failure therapy for Black, Hispanic and American-Indian patients. Card Fail Rev. 2022, 8:e25. 10.15420\/cfr.2022.02","journal-title":"Card Fail Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2022.11.020","article-title":"Sociodemographic disparities in the GDMT usage","volume":"11","author":"Parwani P","year":"2023","unstructured":"Parwani P, Yancy CW. Sociodemographic disparities in the GDMT usage. JACC Heart Fail. 2023, 11:173-5. 10.1016\/j.jchf.2022.11.020","journal-title":"JACC Heart Fail"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0003131","article-title":"Health care is the new battlefront for anti-DEI attacks","volume":"4","author":"Blackstock OJ","year":"2024","unstructured":"Blackstock OJ, Isom JE, Legha RK. Health care is the new battlefront for anti-DEI attacks. PLOS Glob Public Health. 2024, 4:e0003131. 10.1371\/journal.pgph.0003131","journal-title":"PLOS Glob Public Health"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-025-09369-x","article-title":"Perceived discrimination in the healthcare setting and medical mistrust: findings from the Health Information National Trends Survey, 2022","volume":"40","author":"Kaczynski MA","year":"2025","unstructured":"Kaczynski MA, Benitez G, Shehadeh F, Mylonakis E, Fiala MA. Perceived discrimination in the healthcare setting and medical mistrust: findings from the Health Information National Trends Survey, 2022. J Gen Intern Med. 2025, 40:2491-8. 10.1007\/s11606-025-09369-x","journal-title":"J Gen Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry","volume":"72","author":"Greene SJ","year":"2018","unstructured":"Greene SJ, Butler J, Albert NM, et al.. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry. J Am Coll Cardiol. 2018, 72:351-66. 10.1016\/j.jacc.2018.04.070","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.12.015","article-title":"Contemporary treatment patterns and clinical outcomes of comorbid diabetes mellitus and HFrEF: the CHAMP-HF Registry","volume":"8","author":"Vaduganathan M","year":"2020","unstructured":"Vaduganathan M, Fonarow GC, Greene SJ, et al.. Contemporary treatment patterns and clinical outcomes of comorbid diabetes mellitus and HFrEF: the CHAMP-HF Registry. JACC Heart Fail. 2020, 8:469-80. 10.1016\/j.jchf.2019.12.015","journal-title":"JACC Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf784.1291","article-title":"Outpatient prescribing of guideline-directed medical therapy in heart failure","volume":"46","author":"Straw L","year":"2025","unstructured":"Straw L, Lyons L, Mcnamara J, et al.. Outpatient prescribing of guideline-directed medical therapy in heart failure. Eur Heart J. 2025, 46:1. 10.1093\/eurheartj\/ehaf784.1291","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2022.08","article-title":"In-hospital initiation and up-titration of guideline-directed medical therapies for heart failure with reduced ejection fraction","volume":"8","author":"Cox ZL","year":"2022","unstructured":"Cox ZL, Nandkeolyar S, Johnson AJ, Lindenfeld J, Rali AS. In-hospital initiation and up-titration of guideline-directed medical therapies for heart failure with reduced ejection fraction. Card Fail Rev. 2022, 8:e21. 10.15420\/cfr.2022.08","journal-title":"Card Fail Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-025-05187-5","article-title":"Implementation of guideline-directed medical therapy and factors in heart failure with reduced ejection fraction","volume":"25","author":"Bekele FW","year":"2025","unstructured":"Bekele FW, Alemu WA, Tolla KS, Jada AU, Tekle MA, Adem MK, Yesuf HA. Implementation of guideline-directed medical therapy and factors in heart failure with reduced ejection fraction. BMC Cardiovasc Disord. 2025, 25:728. 10.1186\/s12872-025-05187-5","journal-title":"BMC Cardiovasc Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/circ.148.suppl_1.18125","article-title":"Abstract 18125: disparities in HFrEF patients excluded from guideline directed medical therapy at an NYC safety net hospital","volume":"148","author":"Mehta A","year":"2023","unstructured":"Mehta A, Huang A, Chen Y-Y, Faillace R. Abstract 18125: disparities in HFrEF patients excluded from guideline directed medical therapy at an NYC safety net hospital. Circulation. 2023, 148:18125. 10.1161\/circ.148.suppl_1.18125","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pdig.0000868","article-title":"Pharmacist-led rapid uptitration clinic in heart failure patients with reduced ejection fraction: our experience within a virtual ward","volume":"4","author":"Alhakem H","year":"2025","unstructured":"Alhakem H, Murphy A, Fusco L, et al.. Pharmacist-led rapid uptitration clinic in heart failure patients with reduced ejection fraction: our experience within a virtual ward. PLOS Digit Health. 2025, 4:e0000868. 10.1371\/journal.pdig.0000868","journal-title":"PLOS Digit Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jac5.70014","article-title":"The economic impact of the pharmacist in heart failure ambulatory care clinics: a scoping review","volume":"8","author":"Brasseur-Masse J","year":"2025","unstructured":"Brasseur-Masse J, Duguay-Gentile A, Gao C, et al.. The economic impact of the pharmacist in heart failure ambulatory care clinics: a scoping review. JACCP. 2025, 8:347-57. 10.1002\/jac5.70014","journal-title":"JACCP"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2022.08.010","article-title":"The role of a multidisciplinary heart failure clinic in optimization of guideline-directed medical therapy: HF-optimize","volume":"57","author":"Diederich T","year":"2023","unstructured":"Diederich T, Burdorf A, Pozehl B, et al.. The role of a multidisciplinary heart failure clinic in optimization of guideline-directed medical therapy: HF-optimize. Heart Lung. 2023, 57:95-101. 10.1016\/j.hrtlng.2022.08.010","journal-title":"Heart Lung"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacadv.2025.101906","article-title":"Impact of pharmacist telehealth comanagement for heart failure: a nonrandomized controlled study","volume":"4","author":"Fox DS","year":"2025","unstructured":"Fox DS, Zawadski N, Buss K, Leahy A, Zhang QL, Chan YC. Impact of pharmacist telehealth comanagement for heart failure: a nonrandomized controlled study. JACC Adv. 2025, 4:101906. 10.1016\/j.jacadv.2025.101906","journal-title":"JACC Adv"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-024-00646-4","article-title":"Advancing guideline-directed medical therapy in heart failure: overcoming challenges and maximizing benefits","volume":"24","author":"Zhang Z","year":"2024","unstructured":"Zhang Z, Wang C, Tu T, et al.. Advancing guideline-directed medical therapy in heart failure: overcoming challenges and maximizing benefits. Am J Cardiovasc Drugs. 2024, 24:329-42. 10.1007\/s40256-024-00646-4","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499285-gaps-in-guideline-directed-medical-therapy-for-heart-failure-a-cross-sectional-study-in-an-underserved-population","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:35:35Z","timestamp":1782304535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499285-gaps-in-guideline-directed-medical-therapy-for-heart-failure-a-cross-sectional-study-in-an-underserved-population"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.111419","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,24]]}}}